Blackstone Inc
COGT icon

Blackstone Inc’s Cogent Biosciences COGT Stock Holding History

Blackstone Inc’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Buy
+9,382
New +$328K ﹤0.01% 417

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Blackstone Inc's COGT Position: Q2 2026 in Review

Blackstone Inc opened a new position in Cogent Biosciences (COGT) in Q2 2026: 9,382 shares worth $363K. The stake represents ﹤0.01% of the portfolio and ranks #417 among its holdings.

322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Blackstone Inc held 9,382 shares of Cogent Biosciences worth $363K as of Q2 2026.
  • Cogent Biosciences was a new Blackstone Inc position in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Blackstone Inc's portfolio in Q2 2026, its #417 holding.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.